FRATES JAMES M (Chief Financial Officer) received a stock award from AMYLYX PHARMACEUTICALS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 8/21/2026ACC: 0001193125-26-359679
Officer· Chief Financial Officer
Since Jan 2022
+22.81K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
22.81K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+22.81K
Price / share
—
Trade value
—
% of position
10.3%
8/18/2026
221.63K→244.44K
Total
Net shares
+22.81K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/18/2026 | A · Award | +22.81K | — | — | 10.3% | 221.63K | 244.44K |
| Total | +22.81K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)4
Common Stock
IndirectShares owned100K
Common Stock
IndirectShares owned11.07K
Common Stock
IndirectShares owned40K
Common Stock
IndirectShares owned15.46K
Total
166.53K indirect166.53K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 100K | Indirect |
| Common Stock | 11.07K | Indirect |
| Common Stock | 40K | Indirect |
| Common Stock | 15.46K | Indirect |
| Total | 166.53K | 166.53K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported